Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 194 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 194 samples: 84 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL LeukemiaCancer discovery · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE300177_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1279172 and SRA study SRP532497. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 2 samples read as cases, 66 as controls.
How we read this: 84 replicated groups read from 194 sample titles; they account for 176 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8514013 Molm-13, 2500nM PF-9363, 24hrs, rep 1 Molm-13, 2500nM PF-9363…
- GSM8514014 Molm-13, 2500nM PF-9363, 24hrs, rep 2 Molm-13, 2500nM PF-9363…
- GSM8514015 Molm-13, 2500nM PF-9363, 24hrs, rep 3 Molm-13, 2500nM PF-9363…
- GSM8514016 Molm-13, Vehicle, 24hrs, rep 1 Molm-13, Vehicle, 24hrs,
- GSM8514017 Molm-13, Vehicle, 24hrs, rep 2 Molm-13, Vehicle, 24hrs,
- GSM8514018 Molm-13, Vehicle, 24hrs, rep 3 Molm-13, Vehicle, 24hrs,
- GSM8514019 Molm-13, 100nm VTP, 24hrs, rep 1 Molm-13, 100nm VTP, 24h…
- GSM8514020 Molm-13, 100nm VTP, 24hrs, rep 2 Molm-13, 100nm VTP, 24h…
- GSM8514021 Molm-13, 100nm VTP, 24hrs, rep 3 Molm-13, 100nm VTP, 24h…
- GSM8514022 Molm-13, 100nm VTP, 2500nM PF-9363, 24hrs, rep 1 Molm-13, 100nm VTP, 250…
- GSM8514023 Molm-13, 100nm VTP, 2500nM PF-9363, 24hrs, rep 2 Molm-13, 100nm VTP, 250…
- GSM8514024 Molm-13, 100nm VTP, 2500nM PF-9363, 24hrs, rep 3 Molm-13, 100nm VTP, 250…
- GSM8514025 Molm-13, 2500nM PF-9363, 6hrs, rep 1 Molm-13, 2500nM PF-9363…
- GSM8514026 Molm-13, 2500nM PF-9363, 6hrs, rep 2 Molm-13, 2500nM PF-9363…
- GSM8514027 Molm-13, 2500nM PF-9363, 6hrs, rep 3 Molm-13, 2500nM PF-9363…
- GSM8514028 Molm-13, Vehicle, 6hrs, rep 1 Molm-13, Vehicle, 6hrs,
- GSM8514029 Molm-13, Vehicle, 6hrs, rep 2 Molm-13, Vehicle, 6hrs,
- GSM8514030 Molm-13, Vehicle, 6hrs, rep 3 Molm-13, Vehicle, 6hrs,
- GSM8514031 Molm-13, 100nm VTP, 6hrs, rep 1 Molm-13, 100nm VTP, 6hr…
- GSM8514032 Molm-13, 100nm VTP, 6hrs, rep 2 Molm-13, 100nm VTP, 6hr…
- GSM8514033 Molm-13, 100nm VTP, 6hrs, rep 3 Molm-13, 100nm VTP, 6hr…
- GSM8514034 Molm-13, 100nm VTP, 2500nM PF-9363, 6hrs, rep 1 Molm-13, 100nm VTP, 250…
- GSM8514035 Molm-13, 100nm VTP, 2500nM PF-9363, 6hrs, rep 2 Molm-13, 100nm VTP, 250…
- GSM8514036 Molm-13, 100nm VTP, 2500nM PF-9363, 6hrs, rep 3 Molm-13, 100nm VTP, 250…
- GSM9054813 Molm-13, DMSO, MLL IP
- GSM9054814 Molm-13, DMSO, Menin IP
- GSM9054815 Molm-13, PF-9363, MLL IP
- GSM9054816 Molm-13, PF-9363, Menin IP
- GSM9054817 Molm-13, VTP50469, MLL IP
- GSM9054818 Molm-13, VTP50469, Menin IP
- GSM9054819 Molm-13, PF-9363 and VTP50469, MLL IP
- GSM9054820 Molm-13, PF-9363 and VTP50469, Menin IP
- GSM9054821 Molm-13, mixed treatment groups, dual crosslinked IgG antibody for MLL1 IPs
- GSM9054822 Molm-13, mixed treatment groups, single crosslinked IgG antibody for Menin IPs
- GSM9054823 Molm-13, mixed treatment groups, dual crosslinked, 5% input, MLL1
- GSM9054824 Molm-13, mixed treatment groups, single crosslinked, 5% input, Menin
- GSM9054944 M1, BM, Vehicle, rep 1 M1, BM, Vehicle,
- GSM9054945 M1, BM, Vehicle, rep 2 M1, BM, Vehicle,
- GSM9054946 M1, SPL, Vehicle, rep 1 M1, SPL, Vehicle,
- GSM9054947 M1, SPL, Vehicle, rep 2 M1, SPL, Vehicle,
+ 154 more — browse all 194 samples with per-sample file links →
- GSE241650 Pharmaceutical inhibition of RAS overcomes cytokine mediated resistance to FLT3 inhibition in FLT3-ITD+ AML 76 samples shares inhibition, resistance, overcomes
- GSE185651 Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1 mediated cell-intrinsic resistance 28 samples shares inhibition, resistance, inhibitors
- GSE231525 DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [BT474] 12 samples shares inhibition, resistance, overcomes
- GSE248208 Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition 99 samples shares inhibition, resistance
- GSE275078 In vitro drug screening of RAF/MEK/ERK Inhibitors in combination with Autophagy inhibition in the context of two PDA Cell Lines 136 samples shares inhibition, inhibitors
- GSE304612 Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML. [ChIP-seq] 95 samples shares inhibition, catalytic
- GSE254366 Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated CRC. 36 samples shares inhibition, resistance
- GSE303100 Dissecting Resistance to CDK4/6 Inhibition in Experimental Glioma via Genome-wide CRISPR-Cas9 Screening 24 samples shares inhibition, resistance
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.